Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Hutchmed China Ltd (13 HK)
Watchlist
177
Analysis
Industrials
•
Hong Kong
HUTCHMED (China) Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) markets its products worldwide.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hutchmed China Ltd
•
07 Aug 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) 24H1 - Fruquintinib's US Sales Beat; Break-Even Is Within Reach
HUTCHMED's fruquintinib US sales and savolitinib combination with osimertinib for NSCLC will drive future growth. Breakeven in 2025 is expected...
Xinyao (Criss) Wang
Follow
218 Views
Share
bullish
•
Hutchmed China Ltd
•
19 Jun 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - Time to Reassess Valuation Prospects Despite the Pain Points
HUTCHMED’s 2024 full-year sales may once again exceed expectations. It's time to recalculate the peak sales of pipeline and the Company’s outlook....
Xinyao (Criss) Wang
Follow
210 Views
Share
bullish
•
Hutchmed China Ltd
•
12 Mar 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - High Growth Is Expected from 2024 to 2026
HUTCHMED will enter a period of accelerated growth in product revenue based on major catalysts in 2024 to 2026. Global sales of fruquintinib will...
Xinyao (Criss) Wang
Follow
386 Views
Share
bullish
•
Hutchmed China Ltd
•
20 Feb 2024 08:55
Hutchmed China Ltd (13.HK/HCM.US) - 2023 Results Preview and Catalysts in 2024
HUTCHMED has entered a harvest period.Product revenue would grow rapidly in the next two years, with promising catalysts head.Together with...
Xinyao (Criss) Wang
Follow
329 Views
Share
bullish
•
Alibaba Group Holding
•
14 Dec 2022 09:38
China ADRs Delisting - Friday Could Be Judgment Day for over US$800bn Mcap of Stocks
PCAOB officials concluded their Hong Kong visit last month and PCAOB is due to announce its annual judgment on whether it had adequate access to US...
Sumeet Singh
Follow
890 Views
Share
1
2
3
4
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x